On this page, you will find information about a genetic change that was identified in a UDN participant. We are trying to find others with the same or similar condition.
Sharing information on this website is not a requirement of UDN participation. Only descriptions about participants who give explicit consent will appear here.
Changes in the KMT2C gene were identified in two UDN participants. One participant is an 18-year-old male with global developmental delay, autism, severe nearsightedness (myopia), different facial features, and a history of heart defects (atrial septal defect, ventricular septal defect), and cleft palate (read full description). The other participant is a 7-year-old male with global developmental delay, muscle weakness, hand tremor, increased tone in lower limbs (hypertonia), and facial differences (read full description).
Aug 18, 2021
lysine methyltransferase 2C
The KMT2C gene encodes for a histone methyltransferase that modifies chromatin structure and regulates gene transcription through mediation of mono- and tri-methylation of histone H3 at lysine 4 (Koemans et al., 2017).
Changes in this gene were identified in two UDN participants.
Participant 008, an 18-year-old male with global developmental delay, autism, severe nearsightedness (myopia), different facial features, and a history of heart defects (atrial septal defect, ventricular septal defect), and cleft palate was found to carry the following de novo genetic change in the KMT2C gene:
Clinicians and researchers believe that these genetic changes are causing the participant’s symptoms.
Participant 178, a 7-year-old male with global developmental delay, muscle weakness, hand tremor, increased tone in lower limbs (hypertonia), and facial differences was found to carry the following de novo genetic change in the KMT2C gene:
Research is underway to see if this change is causing symptoms in this participant.
Interested in learning more about this gene or sharing what you know? Contact us!